Jupiter Life Line Hospitals Limited
BSE JLHL.BO
Jupiter Life Line Hospitals Limited EBITDA Margin for the year ending March 31, 2024: 24.40%
-
Jupiter Life Line Hospitals Limited EBITDA Margin for the year ending March 31, 2023 was 23.48%, a 10.12% change year over year.
-
Jupiter Life Line Hospitals Limited EBITDA Margin for the year ending March 31, 2022 was 21.32%, a 46.14% change year over year.
-
Jupiter Life Line Hospitals Limited EBITDA Margin for the year ending March 31, 2021 was 14.59%, a -19.14% change year over year.
-
Jupiter Life Line Hospitals Limited EBITDA Margin for the year ending March 31, 2020 was 18.04%.
| Date | EBITDA Margin | EBIT Margin | Depreciation and Amortization | EBIT |
|---|
| CEO | Dr. Ankit Ajay Thakker |
| IPO Date | Sept. 18, 2023 |
| Location | India |
| Headquarters | Jupiter Hospital |
| Employees | 4,586 |
| Sector | Health Care |
| Industries | |
Jupiter Life Line Hospitals Limited, a multi-specialty hospital, provides health care services under the Jupiter brand in India. The company provides treatments in the areas of bariatric surgery, breast care center, cardiac surgery, cardiology, chest medicine, dental care, dermatology, ENT, endocrinology and diabetes, gastroenterology, general surgery and minimal access surgery, HPB and surgical gastroenterology, hematology and BMT, infectious diseases, internal medicine, interventional radiology, mental health, nephrology, neurology, neurosurgery, nutrition and dietetics, Obs and gynecology, oncology, ophthalmology, organ transplant, orthopedics, pediatrics, pain clinic, plastic and cosmetic surgery, rehabilitation, rheumatology, robotic knee replacement, and urology. It also operates breast care center, chest medicine, and pain clinic departments, as well as hotel under the Fortune Park Lake City Hotel name in Thane. The company was incorporated in 2002 and is based in Mumbai, India.
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email